News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Tom Snow: The FDA accepted for Priority Review Sanofi’s application for investigational therapy in multiple myeloma
Photo from Tom Snow/LinkedIn
May 29, 2024, 12:04

Tom Snow: The FDA accepted for Priority Review Sanofi’s application for investigational therapy in multiple myeloma

Tom Snow, General Manager at US Oncology, Sanofi, shared a post on LinkedIn:

“Today, the FDA accepted for Priority Review Sanofi’s application for our investigational combination regimen in newly diagnosed Multiple Myeloma. This important milestone highlights a key step towards potentially addressing the unmet needs of people living with this blood cancer. Read on to learn more here.”

Source: Tom Snow/LinkedIn

cancer FDA multiple myeloma OncoDaily Oncology SANOFI Tom Snow US Oncology
Special Coverage
Blog
Mar 26, 2025, 18:40
The journey living with multiple myeloma can be filled with numerous ups and downs - International Myeloma Foundation
Blog
Mar 26, 2025, 18:32
Juan Gómez Rivas: EAU25 Showcases Science, Innovation, and the Power of Connection in Urology
Blog
Mar 26, 2025, 18:26
Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact - AACR
Blog
Mar 26, 2025, 18:21
Climb of Life Event Has Raised Over £1.5M for Cancer Research Since 2007 - The ICR
Blog
Mar 26, 2025, 18:16
Eric K. Singhi: Breaking news - the Overall Survival results from MARIPOSA are out at ELCC25
Blog
Mar 26, 2025, 18:12
Submit an abstract for the AACR Special Conference
Blog
Mar 26, 2025, 18:03
Molecular tumour board in gastrointestinal cancers
Blog
Mar 26, 2025, 17:58
Enkeleda Duka shares her experience from ESO Clinical Training Centres Fellowship program
Blog
Mar 26, 2025, 17:54
Tbilisi Takes Action to Improve Cancer Care in Georgia - City Cancer Challenge
Blog
Mar 26, 2025, 17:54
Diego A. Díaz García: Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutant advanced NSCLC whose DP on 1L osimertinib
Career
Mar 26, 2025, 17:50
Join UICC as a Fellowships and Grants Coordinator - UICC
Blog
Mar 26, 2025, 17:45
Jenna Dean: The first World Radiotherapy Awareness Day will be held on September 7